Holen Sie sich die Stockscreener-App
1.34
0.37%
-0.01
Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten
Cognition Therapeutics Announces $30.1M Direct Offering - MSN
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Short Interest Up 47.8% in August - MarketBeat
Analyst Upgrade: Will Cognition Therapeutics Inc outperform tech stocksMarket Activity Summary & Free Long-Term Investment Growth Plans - khodrobank.com
FOMO Trade: Is Cognition Therapeutics Inc a good stock for dollar cost averagingPortfolio Gains Report & Technical Pattern Recognition Alerts - خودرو بانک
Earnings Miss: Is Cognition Therapeutics Inc stock a top performer YTDWeekly Stock Report & Real-Time Stock Entry Alerts - خودرو بانک
Published on: 2025-09-19 07:05:54 - خودرو بانک
Loss Report: Is Cognition Therapeutics Inc stock a top performer YTDEarnings Beat & Capital Protection Trading Alerts - khodrobank.com
Technical Analysis: Is Axsome Therapeutics Inc gaining market share2025 Support & Resistance & Consistent Profit Trading Strategies - khodrobank.com
Earnings Risk: Whats the fair value of Cognition Therapeutics Inc stock2025 Analyst Calls & High Accuracy Investment Signals - khodrobank.com
Is Cognition Therapeutics Inc stock heavily shortedPortfolio Update Report & Community Driven Trade Alerts - خودرو بانک
Geopolitics Watch: Can EWCZ outperform in the next rallyRisk Management & AI Powered Market Entry Ideas - khodrobank.com
Smart Money: Is Cognition Therapeutics Inc. a good stock for dollar cost averagingPortfolio Update Summary & AI Based Trade Execution Alerts - خودرو بانک
Earnings Recap: Can Cognition Therapeutics Inc reach resistance levels soonJuly 2025 Levels & Daily Momentum Trading Reports - خودرو بانک
IPO Launch: Can Cognition Therapeutics Inc disrupt its industryWeekly Gains Summary & Real-Time Volume Surge Alerts - خودرو بانک
Update Recap: Is BARK stock a falling knife or bargain buy2025 Volume Leaders & Safe Capital Investment Plans - khodrobank.com
Update Recap: Is Cognition Therapeutics Inc in a long term uptrendOptions Play & Community Verified Trade Signals - خودرو بانک
FOMO Trade: Will Cognition Therapeutics Inc outperform tech stocksJuly 2025 Catalysts & Long-Term Growth Plans - خودرو بانک
Risk Check: Does Cognition Therapeutics Inc. have pricing power2025 Sector Review & Daily Stock Trend Watchlist - khodrobank.com
Cognition Therapeutics Advances Zervimesine to Phase 3 Trials - TipRanks
Weekly Recap: Whats next for Cognition Therapeutics Inc stockGlobal Markets & AI Based Buy/Sell Signal Reports - خودرو بانک
Aug Mood: Is Cognition Therapeutics Inc. trading at a discountPortfolio Update Summary & Daily Risk Controlled Trade Plans - خودرو بانک
Cognition Therapeutics (NASDAQ:CGTX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
CGTX Q3 EPS Estimate Raised by Brookline Capital Management - MarketBeat
Is Cognition Therapeutics Inc. a good stock for dollar cost averagingPortfolio Value Summary & Weekly Top Performers Watchlists - Lancaster City Council
Cognition Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement - 富途牛牛
Visualizing Cognition Therapeutics Inc. stock with heatmapsPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Cognition Therapeutics Regains Nasdaq Compliance - MSN
Cognition Therapeutics Inc. stock retracement – recovery analysisInsider Buying & Daily Stock Trend Watchlist - Newser
Is Cognition Therapeutics Inc. Forming a Bottom PatternMarket Sentiment Review & Weekly Momentum Stock Picks - beatles.ru
Chart overlay techniques for tracking Cognition Therapeutics Inc.2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Cognition Therapeutics Inc. stock prediction for this weekTreasury Yields & Daily Chart Pattern Signal Reports - Newser
Tick level data insight on Cognition Therapeutics Inc. volatilityMarket Trend Report & Fast Moving Stock Trade Plans - Newser
Can Cognition Therapeutics Inc. keep up with sector leaders2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
What moving averages say about Cognition Therapeutics Inc.2025 Retail Activity & High Yield Stock Recommendations - Newser
Exit Recap: Is Cognition Therapeutics Inc. a stock for growth or value investorsWeekly Market Report & Growth Focused Investment Plans - خودرو بانک
Backtesting results for Cognition Therapeutics Inc. trading strategiesMarket Risk Report & Reliable Entry Point Trade Alerts - Newser
Published on: 2025-09-05 00:35:53 - Newser
Published on: 2025-09-05 00:14:17 - Newser
Real time pattern detection on Cognition Therapeutics Inc. stockRisk Management & Advanced Technical Signal Analysis - Newser
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock - 富途牛牛
Support Zone Holds Steady for Cognition Therapeutics Inc. After DipMarket Weekly Review & Weekly High Conviction Ideas - Newser
Multi asset correlation models including Cognition Therapeutics Inc.Market Activity Report & Daily Profit Maximizing Trade Tips - Newser
Cognition Therapeutics Inc. stock trend forecastTrade Entry Summary & Breakout Confirmation Trade Signals - Newser
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone By Investing.com - Investing.com Canada
Top chart patterns to watch in Cognition Therapeutics Inc.Weekly Trend Report & Safe Capital Growth Plans - Newser
How to manage a losing position in Cognition Therapeutics Inc.Earnings Overview Report & Low Risk High Win Rate Picks - Newser
Can Cognition Therapeutics Inc. recover in the next quarter2025 Retail Activity & Daily Profit Focused Stock Screening - Newser
How sentiment analysis helps forecast Cognition Therapeutics Inc.Quarterly Growth Report & Daily Entry Point Alerts - Newser
Real time scanner hits for Cognition Therapeutics Inc. explainedTreasury Yields & Community Verified Swing Trade Signals - Newser
Cognition Therapeutics closes $30 million registered direct offering By Investing.com - Investing.com Australia
Does Cognition Therapeutics Inc. have pricing power2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - khodrobank.com
Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone - Investing.com
Trend analysis for Cognition Therapeutics Inc. this weekPortfolio Update Summary & AI Powered Trade Plan Recommendations - Newser
Cognition Therapeutics, Inc. Achieves 75% Enrollment in Phase 2 START Study for Early Alzheimer’s Disease Treatment - Quiver Quantitative
2.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):